MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/toxsci/kfu269

Медицинская библиотека · Toxicological sciences : an official journal of the Society of Toxicology · 2014

MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.

Kia Richard, Kelly Lorna, Sison-Young Rowena L C, Zhang Fang, Pridgeon Chris S, Heslop James A, Metcalfe Pete, Kitteringham Neil R, Baxter Melissa, Harrison Sean, Hanley Neil A, Burke Zoë D, Storm Mike P, Welham Melanie J, Tosh David, Küppers-Munther Barbara, Edsbagge Josefina, Starkey Lewis Philip J, Bonner Frank, Harpur Ernie, Sidaway James, Bowes Joanne, Fenwick Stephen W, Malik Hassan, Goldring Chris E P, Park B Kevin

Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Emerging hepatic models for the study of drug-induced toxicity include pluripotent stem cell-derived hepatocyte-like cells (HLCs) and complex hepatocyte-non-parenchymal cellular coculture to mimic the complex multicellular interactions that recapitulate the niche environment in the human liver. However, a specific marker of hepatocyte perturbation, required to discriminate hepatocyte damage from non-specific cellular toxicity contributed by non-hepatocyte cell types or immature differentiated cells is currently lacking, as the cytotoxicity assays routinely used in in vitro toxicology research depend on intracellular molecules which are ubiquitously present in all eukaryotic cell types. In this study, we demonstrate that microRNA-122 (miR-122) detection in cell culture media can be used as a hepatocyte-enriched in vitro marker of drug-induced toxicity in homogeneous cultures of hepatic cells, and a cell-specific marker of toxicity of hepatic cells in heterogeneous cultures such as HLCs generated from various differentiation protocols and pluripotent stem cell lines, where conventional cytotoxicity assays using generic cellular markers may not be appropriate. We show that the sensitivity of the miR-122 cytotoxicity assay is similar to conventional assays that measure lactate dehydrogenase activity and intracellular adenosine triphosphate when applied in hepatic models with high levels of intracellular miR-122, and can be multiplexed with other assays. MiR-122 as a biomarker also has the potential to bridge results in in vitro experiments to in vivo animal models and human samples using the same assay, and to link findings from clinical studies in determining the relevance of in vitro models being developed for the study of drug-induced liver injury.

Для цитирования: Kia Richard, Kelly Lorna, Sison-Young Rowena L C, Zhang Fang, Pridgeon Chris S, Heslop James A, Metcalfe Pete, Kitteringham Neil R, Baxter Melissa, Harrison Sean, Hanley Neil A, Burke Zoë D, Storm Mike P, Welham Melanie J, Tosh David, Küppers-Munther Barbara, Edsbagge Josefina, Starkey Lewis Philip J, Bonner Frank, Harpur Ernie, Sidaway James, Bowes Joanne, Fenwick Stephen W, Malik Hassan, Goldring Chris E P, Park B Kevin. MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity.. Toxicological sciences : an official journal of the Society of Toxicology. 2014. DOI: 10.1093/toxsci/kfu269.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.